Universe Pharmaceuticals INC Additional Paid in Capital, Common Stock
Universe Pharmaceuticals INC (UPC) had Additional Paid in Capital, Common Stock of $63.01 billion as of 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-01-29
- 2025-09-30: Additional Paid in Capital, Common Stock $63.01B.
- 2024-09-30: Additional Paid in Capital, Common Stock $53.86B; Additional Paid in Capital, Common Stock as first filed $53.86M.
- 2024-03-31: Additional Paid in Capital, Common Stock $29.28M.
- 2023-09-30: Additional Paid in Capital, Common Stock $29.28M; Additional Paid in Capital, Common Stock as first filed $29.28M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2025-09-30 | $63.01B 20-F · filed 2026-01-29 | |
| 2024-09-30 | $53.86B 20-F · filed 2026-01-29 | $53.86M 20-F · filed 2025-04-29 |
| 2024-03-31 | $29.28M 6-K · filed 2024-09-20 | |
| 2023-09-30 | $29.28M 20-F · filed 2025-04-29 | $29.28M 20-F · filed 2024-01-30 |
| 2022-09-30 | $29.28M 20-F · filed 2024-01-30 |